Servier Pharmaceuticals

Last week, we celebrated Bring Your Child to Work Day with a full day of hands-on #STEAM activities! Supporting the families who make up our #Servier community is at the heart of our commitment to culture. Thank you to everyone who helped bring this exciting day to life!

Servier has completed the acquisition of Day One Biopharmaceuticals, with Day One joining Servier US. Together, we unite scientific, clinical, and commercial strengths to advance innovative oncology medicines for patients and families, including those affected by rare cancers.

Happy #AdministrativeProfessionalsDay to our incredible administrative team whose behind-the-scenes dedication keeps us running & drives us forward. Today and every day, we recognize the talent, professionalism, and unwavering support you bring to the teams across #Servier.

Today, we join the global community in recognizing #AMLWorldLAwarenessDay. At Servier, this day serves as a powerful reminder of our ongoing mission: to raise awareness, share resources, and advocate for the patients we serve every day. Learn more: lnkd.in/e9dPrtUP

Today is a big day in our hometown! Good luck to all our Servier colleagues & friends running the #BostonMarathon – we're cheering for you every step of the way. We're proud to call Boston home, a city defined by innovation, community, and determination. #BostonStrong

We’re looking forward to connecting with the global oncology community at this year’s #AACR Annual Meeting. In #SanDiego this weekend? We hope to see you there!

Patient voices shape everything we do, especially in #rareneurology. Working early with patient advocacy groups helps us rethink disease understanding and design trials that reflect patients' needs. Discover how this is shaping our approach to research: servier.us/blog/listening…

Data play a critical role in improving patient outcomes. #Servier is #hiring an Associate Director, #Biostatistics to generate real-world evidence that informs key decisions. Passionate about healthcare evidence? Apply here: lnkd.in/eg_icTHp

This week is #AYACancerAwarenessWeek. At Servier, we’re committed to understanding the needs of AYA patients. Through our Patient Expert Council, we bring lived experiences into everything we do to help better meet patient needs. Learn more: lnkd.in/eyHurix8

As Walid Kamoun marks his fourth anniversary at Servier, we sat down with him to discuss his journey, his approach to oncology R&D, and how the rapidly evolving oncology landscape continues to shape his work. Read the interview here: servier.us/blog/a-new-era… @wskamoun

In the spirit of @WHO's theme for this year’s #World Health Day, “Together for health. Stand with science,” our team shared what this means to them, and how science shows up in their work every day. Scroll to learn about their perspectives, and just us as we #StandWithScience.

#Servier is hiring an Associate Director, U.S. Analytics to help shape data-driven strategy across our Hematology Oncology business unit. Join our growing team and make a direct impact on our mission to bring meaningful therapies to patients. Apply here: lnkd.in/e_x4nY5g

Servier team members were proud to participate in the 2026 State of Possible Conference hosted by @MassBio. The event brought together leaders across the Massachusetts life sciences community to spotlight the people, passion, and purpose driving scientific innovation forward.

Curious about life at Servier? Our colleagues share what makes our culture unique – strong values, meaningful work, and a shared commitment to making a difference. For more on open roles and Servier culture, visit: lnkd.in/gRWqxyj9

As we near the end of Women's History Month, we’re reflecting on the @officialNWHA theme: “Leading the Change: Women Shaping a Sustainable Future.” Embracing this theme, we asked team members to share who inspires them in leading the change. Learn more: lnkd.in/ggdfgyC

Did you know gliomas are the most common primary type of brain tumor? Mutational testing is recommended for all patients with glioma, helping to better classify tumors and guide personalized care. Learn more: lnkd.in/e_i7mBjD

Servier is hiring a Senior Director, U.S. Product & Pipeline Communications to help to help lead strategic storytelling across our expanding portfolio and pipeline. If you’re an experienced healthcare communications leader, apply here: lnkd.in/es35zCQ4

While significant progress has been made in advancing cancer medicines, we know there is much more work to be done. At #Servier, we are focused on advancing targeted therapies for patients affected by cancer. Learn more about our research efforts: lnkd.in/esSSHFz3

In celebration of #IWD2026 and this year’s theme, #GiveToGain, we’re proud to spotlight Servier leaders as they reflect on the people, experiences, and opportunities that have shaped their journeys. Read their empowering advice in our latest blog: lnkd.in/ey_k9uGM

Today, Servier announced the acquisition of @DayOneBio, an important step in advancing care for low-grade glioma patients and strengthening Servier's global capabilities in rare oncology. servier.mediaroom.com/news-releases?…